These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 35242941)
21. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice. Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666 [TBL] [Abstract][Full Text] [Related]
22. High-fat diet action on adiposity, inflammation, and insulin sensitivity depends on the control low-fat diet. Benoit B; Plaisancié P; Awada M; Géloën A; Estienne M; Capel F; Malpuech-Brugère C; Debard C; Pesenti S; Morio B; Vidal H; Rieusset J; Michalski MC Nutr Res; 2013 Nov; 33(11):952-60. PubMed ID: 24176235 [TBL] [Abstract][Full Text] [Related]
23. Metabolic phenotype in the mouse model of osteogenesis imperfecta. Boraschi-Diaz I; Tauer JT; El-Rifai O; Guillemette D; Lefebvre G; Rauch F; Ferron M; Komarova SV J Endocrinol; 2017 Sep; 234(3):279-289. PubMed ID: 28716975 [TBL] [Abstract][Full Text] [Related]
24. Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse. Cardinal M; Chretien A; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Manicourt DH; Behets C Front Genet; 2021; 12():705505. PubMed ID: 34447412 [TBL] [Abstract][Full Text] [Related]
25. Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta. Kocijan R; Muschitz C; Fratzl-Zelman N; Haschka J; Dimai HP; Trubrich A; Bittighofer C; Resch H Skeletal Radiol; 2013 Feb; 42(2):187-94. PubMed ID: 22955449 [TBL] [Abstract][Full Text] [Related]
26. Diet-induced obesity causes insulin resistance in mouse brown adipose tissue. Roberts-Toler C; O'Neill BT; Cypess AM Obesity (Silver Spring); 2015 Sep; 23(9):1765-70. PubMed ID: 26242777 [TBL] [Abstract][Full Text] [Related]
27. Omega-3 fatty acids protect from diet-induced obesity, glucose intolerance, and adipose tissue inflammation through PPARγ-dependent and PPARγ-independent actions. Belchior T; Paschoal VA; Magdalon J; Chimin P; Farias TM; Chaves-Filho AB; Gorjão R; St-Pierre P; Miyamoto S; Kang JX; Deshaies Y; Marette A; Festuccia W Mol Nutr Food Res; 2015 May; 59(5):957-67. PubMed ID: 25641959 [TBL] [Abstract][Full Text] [Related]
28. Short-term thermoneutral housing alters glucose metabolism and markers of adipose tissue browning in response to a high-fat diet in lean mice. Clayton ZS; McCurdy CE Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R627-R637. PubMed ID: 29791203 [TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up in osteogenesis imperfecta type VI. Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307 [TBL] [Abstract][Full Text] [Related]
31. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta. Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315 [TBL] [Abstract][Full Text] [Related]
32. Adipose tissue (P)RR regulates insulin sensitivity, fat mass and body weight. Shamansurova Z; Tan P; Ahmed B; Pepin E; Seda O; Lavoie JL Mol Metab; 2016 Oct; 5(10):959-969. PubMed ID: 27689008 [TBL] [Abstract][Full Text] [Related]
33. Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta. Tauer JT; Abdullah S; Rauch F J Bone Miner Res; 2019 Feb; 34(2):207-214. PubMed ID: 30357929 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse bone. Vanleene M; Shefelbine SJ Bone; 2013 Apr; 53(2):507-14. PubMed ID: 23352925 [TBL] [Abstract][Full Text] [Related]
35. Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice. McGillicuddy FC; Reynolds CM; Finucane O; Coleman E; Harford KA; Grant C; Sergi D; Williams LM; Mills KH; Roche HM Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E834-44. PubMed ID: 23921145 [TBL] [Abstract][Full Text] [Related]
36. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis. Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278 [TBL] [Abstract][Full Text] [Related]
37. Emodin Improves Glucose and Lipid Metabolism Disorders in Obese Mice Cheng L; Zhang S; Shang F; Ning Y; Huang Z; He R; Sun J; Dong S Front Endocrinol (Lausanne); 2021; 12():618037. PubMed ID: 34040579 [TBL] [Abstract][Full Text] [Related]
38. TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway. Ghoshal S; Zhu Q; Asteian A; Lin H; Xu H; Ernst G; Barrow JC; Xu B; Cameron MD; Kamenecka TM; Chakraborty A Mol Metab; 2016 Oct; 5(10):903-917. PubMed ID: 27689003 [TBL] [Abstract][Full Text] [Related]
39. Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta. Bateman JF; Sampurno L; Maurizi A; Lamandé SR; Sims NA; Cheng TL; Schindeler A; Little DG J Cell Mol Med; 2019 Mar; 23(3):1735-1745. PubMed ID: 30597759 [TBL] [Abstract][Full Text] [Related]
40. Brown adipose tissue blood flow and mass in obesity: a contrast ultrasound study in mice. Clerte M; Baron DM; Brouckaert P; Ernande L; Raher MJ; Flynn AW; Picard MH; Bloch KD; Buys ES; Scherrer-Crosbie M J Am Soc Echocardiogr; 2013 Dec; 26(12):1465-73. PubMed ID: 23993691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]